Mary Kay Introduces the K-Beauty Texture Edit
5.10.2026 14:02:00 CEST | Business Wire | Press Release
Mary Kay Inc.,the iconic beauty giant announced today the launch of the K-Beauty Texture Edit, aspecial-edition skin care collection available while supplies last. The collection builds on the momentum of the company's largest consumer-facing global brand platform, Beauty Is More Beautiful Shared™ which launched in September.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005600130/en/
Mary Kay's Special Edition K-Beauty Texture Edit is a trend-forward collection which includes three Korea-made products: the Mary Kay® Melt-In Cleansing Balm, Mary Kay® Snail Gel Face Patches and Mary Kay® Collagen Moisturizing Gel. (Image Credit: Mary Kay Inc.)
Inspired by Korea's globally influential skin care and self-care philosophy designed to bring playful textures, innovative ingredients, and elevated beauty experiences, the K-Beauty Texture Editwas designed to resonate with a global cultural beauty movement captivating the next generation. The trend-forward collection includes three Korea-made products: the Mary Kay® Melt-In Cleansing Balm, Mary Kay® Snail Gel Face Patches and Mary Kay® Collagen Moisturizing Gel.
The launch marks another exciting milestone in Mary Kay's ongoing evolution as the company expands its global reach, connects with a new generation of beauty enthusiasts and continues to support the Independent Beauty Consultants and loyal customers who have powered its success for decades.
Launching just one month after the debut of Beauty Is More Beautiful Shared™, the K-Beauty Texture Edit brings the platform’s philosophy to life through products designed to spark discovery, conversation, and shared beauty experiences. It also reflects Mary Kay’s strategy of blending globally inspired innovation with the personalized service and relationships that remain central to the Mary Kay experience.
“Mary Kay’s legacy has always been rooted in innovation, listening to consumers, and evolving with the culture of beauty around the world,” said Dr. Lucy Gildea, Chief Brand and Scientific Officer of Mary Kay Inc. “The K-Beauty Texture Edit brings that spirit to life by translating global beauty trends into meaningful experiences for consumers and our Independent Beauty Consultants. As part of Beauty Is More Beautiful Shared™, it also helps us build awareness and relevance with the next generation of beauty consumers while honoring the heritage that connects us all.”
The Mary Kay K-Beauty Texture Edit includes three familiar steps – cleansing, patches, and moisturizing – in fun, sensorial formats. Each product fits easily into an existing routine, so customers can try something new without changing what already works. The collection features:
- Mary Kay® Melt-In Cleansing Balm – a transformative balm-to-oil-to-milky cleanser featuring regenerative PDRN1 (salmon DNA) infusion, rice bran oil, and vitamin E that helps leave skin feeling soft and clean.
- Mary Kay® Snail Gel Face Patches – cooling hydrogel face patches formulated with snail mucin, niacinamide, licorice extract, and multiple forms of hyaluronic acid to help hydrate and brighten the appearance of skin.
- Mary Kay® Collagen Moisturizing Gel – a bouncy jelly moisturizer featuring collagen peptides, niacinamide, and squalane to deliver hydration and a plump, glass-skin-inspired glow.
The K-Beauty Texture Edit was created to appeal to next-generation consumers while remaining accessible to existing customers, pairing trend-driven innovation with a distinct Mary Kay approach to beauty and relationships across generations.
Through its global network of Independent Beauty Consultants, Mary Kay continues to create personalized beauty experiences that connect customers with products, education, and community. The K-Beauty Texture Edit extends that opportunity by giving consumers a fresh way to explore one of the world's most influential beauty movements through a trusted global brand.
The Mary Kay K-Beauty Texture Edit will be available beginning October 5, 2026, on Mary Kay’s website and through Mary Kay Independent Beauty Consultants in participating markets worldwide, while supplies last.
Beyond ongoing product innovation, Mary Kay recently announced new ways to invite the next generation of consumers to engage with the brand:
- Mary Kay’s My Shop platform: Launched in the U.S. and Germany in 2025, expanded into Canada, Mexico and Spain this summer, “My Shop” is being progressively rolled out globally. My Shop has been designed to meet consumer buying experience needs and speak to a digitally native generation who demand convenience, choice and seamless interactions all in one. The Mary Kay My Shop also provides Independent Beauty Consultants with personalized digital storefronts connected to e-commerce, payments, fulfilment and social media empowering them to serve customers where they are.
- In March 2026, Mary Kay launched its “Global Social Squad” bringing together more than 70 Independent Beauty Consultants across 15 markets as social creators.
- Beauty Tech: Mary Kay’s AI-powered Foundation Finder analyzes 151 facial points to recommend shades directly from the phone in just seconds. Mary Kay Foundation Finder was recently recognized as a finalist in the 2026 Gartner Eye on Innovation Awards for Retail & Consumer Goods.
Did You Know:
- Mary Kay ranked #8 out of 5,500 brands on Forbes’s 2026 Best Brands for Social Impact2moving up from stellar #9 achieved in 2025. Mary Kay is the only beauty brand in the Top 15 and the only direct selling company on the list.
- Mary Kay ranked #2 on Forbes 2026 Best Customer Service list moving up from #93 in 20253. Mary Kay is the only Beauty brand in the Top 15 and the only direct-selling company in the Top 50.
- Mary Kay was named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World4 by Euromonitor International for four consecutive years (2023-2026).
ABOUT MARY KAY
For more than 60 years, Mary Kay has empowered generations of women around the world to discover beauty together, build meaningful futures and find a community of women who celebrate one another. Founded by Mary Kay Ash in 1963, the global beauty company has connected women across 40 markets through innovative skincare, color cosmetics, fragrances, and wellness products. Mary Kay transforms purpose into action by advancing causes that support women and families, investing in scientific innovation, and working toward a more sustainable future. At its core, Mary Kay is dedicated to enriching women's lives and creating opportunities for women to thrive together. Learn more at marykayglobal.com. Find us on Facebook, Instagram, and LinkedIn.
| ____________________________________ |
1 Polydeoxyribonucleotide (PDRN) is a mix of purified Salmon DNA fragments. |
2 Alan Schwarz (March 17, 2026). Forbes - Best Brands For Social Impact 2026. https://www.forbes.com/lists/best-brands-social-impact/ |
3 Alan Schwarz (October 14, 2025). Forbes - Best Customer Service 2026. https://www.forbes.com/lists/best-customer-service/ |
4 “Source Euromonitor International Limited; Beauty and Personal Care 2026 Edition, Value Sales at RSP, 2025 Data” |
View source version on businesswire.com: https://www.businesswire.com/news/home/20261005600130/en/
Contacts
Mary Kay Inc. Corporate Communications
newsroom.marykay.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fnewsroom.maryka
y.com&esheet=54615169&newsitemid=20261005600130&lan=en-US&anchor=newsroom.maryka
y.com&index=12&md5=a9f48c13f500c2ee53941e2f35ec6d77
972.687.5332 or media@mkcorp.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.5.10.2026 14:00:00 CEST | Press Release
GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subject to closing conditions, including regulatory approvals, at which time SOFIE Biosciences will become part of GE HealthCare’s PDx segment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005273717/en/ SOFIE Biosciences has 15 CMO sites across the U.S., manufacturing PET radiopharmaceutical products The acquisition of SOFIE Biosciences establishes a footprint for GE HealthCare in the time-critical ‘final mile’ of U.S. PET radiopharmaceutical supply, while also enabling PDx to participate in other high growth areas outside its own product portfolio. With a U.S. network of 15 CMO sites operating 21 cyclotrons, and a theranostics
Henkell Freixenet Strengthens Premium Dealcoholized Sparkling Wine Production with Solos' Patented Aroma Recovery System5.10.2026 13:24:00 CEST | Press Release
Henkell Freixenet is expanding its premium dealcoholized sparkling wine production capabilities through the deployment of Solos Technology's patented Aroma Recovery System (ARS) at its Wiesbaden production site, the Group’s expertise centre for alcohol-free production. The installation represents a significant investment in next-generation dealcoholized sparkling wine production, helping preserve the natural aroma and sensory identity of the original wines. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005959301/en/ Fürst von Metternich Riesling Alcohol-free on the bottling line, one of the first products in Henkell Freixenet’s portfolio developed in collaboration with Solos Technology. The project combines Henkell Freixenet's longstanding winemaking expertise with Solos' proprietary dealcoholization and patented aroma recovery technology. With 30 years of experience in producing alcohol-free sparkling wines, Henkell Fre
Croma-Pharma Expands Its Portfolio in Canada With saypha ® lips Lidocaine and Exprecell™5.10.2026 13:12:00 CEST | Press Release
Croma-Pharma continues to build its portfolio in Canada, adding saypha® lips Lidocaine, a hyaluronic acid filler for lip augmentation,1 and Exprecell™, a medical device for the preparation of autologous PRP | Fluid-PRF.2 Both are distributed by Renellence, Croma's partner in Canada since 2025. The two additions reflect Croma's broader approach: pairing established hyaluronic acid expertise with autologous, regenerative technologies. Together, they give practitioners options across both aesthetic and regenerative treatment categories, from a single trusted source. "With saypha® lips Lidocaine and Exprecell™, we're giving Canadian practitioners a wider set of tools for facial aesthetics and regenerative treatments, each held to the same standard of precision and safety," said Andreas Prinz, Chief Executive Officer of Croma-Pharma GmbH. Renellence has distributed Croma's Saypha® hyaluronic acid filler range in Canada since October 2025, alongside medical education and training for Canadia
Anaeco Secures Strategic Investment from Momentum Global Ventures to Accelerate Commercial Deployment5.10.2026 12:00:00 CEST | Press Release
Anaeco, Inc., a clean technology company developing systems to destroy harmful and difficult-to-abate gases, today announced a strategic investment from Momentum Global Ventures. The investment supports Anaeco as it moves from technology development and validation to commercial deployment across three initial markets: anesthetic gases, refrigerants, and semiconductor manufacturing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005546122/en/ Anaeco’s technology exploits atmospheric chemistry to destroy harmful, high-impact gases, including HFCs, PFAS, anesthetic gases, N2O, and other difficult-to-abate emissions at their source. By accelerating processes that naturally transform pollutants, its modular technology provides a practical, scalable approach to emissions that are difficult or costly to manage conventionally. Initial Commercial Verticals Anesthetics: Destroying anesthetic gases generated in healthcare environmen
Worldwide First: Biedermann Motech Further Expands its MOSS!MODULARITY Platform with the Addition of MOSS EOS for Early Onset Scoliosis Surgery5.10.2026 11:00:00 CEST | Press Release
Biedermann Motech, the prominent innovator in next generation spinal and extremity implant systems and procedural solutions, today announced the selective market introduction of the MOSS EOS® System for the treatment of children with severe early onset scoliosis.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005092768/en/ Early Onset Scoliosis is a rare pediatric disease where in certain cases surgical intervention can be indicated.2 Breaking new ground, Biedermann Motech will now introduce the world’s first MOSS EOS System featuring MOSS!MODULARITY™ to selective markets outside the U.S. The MOSS EOS System encompasses a modular platform of products and technologies for growth friendly pediatric spinal deformity surgery. Prof. Dr. Heiko Koller from Germany, one of the innovators behind the MOSS EOS System, carried out the first surgeries. His feedback was that the versatility of the system offers surgeons a broad range
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom